The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches - Concepedia

Concepedia

Publication | Closed Access

The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches

44

Citations

13

References

2020

Year

Fabio Salvatore Macaluso, Walter Fries, Anna Viola, Andrea Centritto, Maria Cappello, E Giuffrida, Antonino Carlo Privitera, Giovita Piccillo, Antonio Magnano, E Vinci,

Inflammatory Bowel Diseases

Abstract

The safety and effectiveness of SB2 seem to be overall similar to those reported for the IFX originator and CT-P13.

References

	Year	Citations

Page 1